Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05179408 · ClinicalTrials.gov registry record · NA

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

A NA study of Lung Cancer and Cancer Survivors, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05179408: Recruiting NA study of Lung Cancer and Cancer Survivors, sponsored by VA Office of Research and Development.

NCT05179408 is a NA study of Lung Cancer and Cancer Survivors that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 40 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05179408, a NA study of Lung Cancer and Cancer Survivors, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Lung cancer is the second-most commonly diagnosed cancer among U.S. Veterans. Substantial advances have been made in early detection through screening and treatment. The longevity of Veterans following lung cancer diagnosis and treatment has increased. Following treatment however, many Veterans experience increased symptom burden, particularly in shortness of breath, fatigue, and fear/anxiety about lung cancer, and impairments in physical and psychosocial functioning. Rehabilitation services are needed to address these survivorship challenges. This study will evaluate multi-targeted telerehabilitation with Veterans following lung cancer treatment, with goals to reduce symptom burden, improve physical and psychosocial function, and enhance health-related quality of life. This research will also develop the career of a physician researcher to acquire expertise in rehabilitation for many Veteran survivors of lung and other cancers.

Primary Outcome

Global health-related quality of life (EORTC QLQ C30 global/QoL subscale)

Interventions

  • BEHAVIORAL Waitlist
  • BEHAVIORAL Targeted-telerehabilitation

Study Locations (1)

Colorado

  • Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-01-12
Est. Completion 2027-03-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05179408 shows while recruiting

NCT05179408 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Waitlist is the first listed.

NCT05179408 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT05179408 about?

NCT05179408 is a clinical study titled "Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer". Lung cancer is the second-most commonly diagnosed cancer among U.S. Veterans. Substantial advances have been made in early detection through screening and treatment. The longevity of Veterans following lung cancer diagnosis and treatment has increased. Following treatment however, many Veterans expe...

What is the current status of trial NCT05179408?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-01-12. Estimated completion is 2027-03-30.

What conditions does trial NCT05179408 study?

This clinical trial studies the following conditions: Lung Cancer, Cancer Survivors.

What interventions are being tested in trial NCT05179408?

The interventions under investigation include: Waitlist (BEHAVIORAL), Targeted-telerehabilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05179408?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05179408 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05179408's enrollment target sits among peer trials

40 294th of 409 higher than 108 of 409 other Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05179408, the US trial registry maintained by the National Library of Medicine. NCT05179408 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.